Moxifloxacin vs Rituximab
Moxifloxacin vs Rituximab: Overview
This comparison examines the pharmacological differences between Moxifloxacin and Rituximab.
Mechanism of Action
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Moxifloxacin β 12 hours; Rituximab β 22 days.
Chemical Properties
Molecular Formula: Moxifloxacin β C21H24FN3O4.
Molecular Weight: Moxifloxacin β 401.4350 g/mol.
Type: Moxifloxacin β Small molecule; Rituximab β Antibody.